Bruker and Evosep announce major progress in unbiased, quantitative true single-cell proteomics – News-Medical.net

Bruker Corporation and Evosep today announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.
Evosep One is a chromatography system that delivers fast, sensitive and robust proteomic analysis of clinical samples, while supporting connections to a wide range of mass spectrometers.
These advances have been demonstrated by the Mann-group in a paper by A. Brunner et…

Click here to view the original article.